Transcriptomics Technologies Market by Technologies (Gene Regulation, Microarrays, Next Generation Sequencing, Polymerase Chain Reaction), and Applications (Bioinformatics, Clinical Diagnostics, Comparative Transcriptomics, Drug Discovery and Research) and Forecast 2017-2021

Transcriptomics Technologies Market by Technologies (Gene Regulation, Microarrays, Next Generation Sequencing, Polymerase Chain Reaction), and Applications (Bioinformatics, Clinical Diagnostics, Comparative Transcriptomics, Drug Discovery and Research) and Forecast 2017-2021

The transcriptome is the set of all messenger RNA molecules in one cell or a population of cells. It differs from the exome in that it includes only those RNA molecules found in a specified cell population, and usually includes the amount or concentration of each RNA molecule in addition to the molecular identities. The major technologies employed for transcriptome analysis comprises microarrays, PCR, gene regulation studies and next generation sequencing technologies. Gene expression analysis has become easy, cheap, and fast routine due to microarrays and now RNA sequencing, which is helping researchers discover novel RNA forms and variants. New technologies promise to reveal even more about RNA and make RNA-based clinical assays common. High throughput transcriptomics became possible with microarrays, which detect nucleic acids in a sample by hybridization to probes on microchips. Microarrays are particularly useful for analyzing large mammalian transcriptomes, for example in drug development and clinical research that requires rapidly assessing specific genes in thousands of samples.

The global transcriptomics technologies market report provides market size (Revenue USD Million 2014 to 2021), market share and forecasts growth trends (CAGR%, 2017 to 2021).

The global transcriptomics technologies market segmentation is based on technologies (gene regulation, microarrays, next generation sequencing, polymerase chain reaction), and its applications (bioinformatics, clinical diagnostics, comparative transcriptomics, drug discovery and research).

The global transcriptomics technologies market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market and provides analysis of the company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market. The global transcriptomics technologies market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

Major players operating in the global transcriptomics technologies market and included in this report are Agilent Technologies, Affymetrix, Inc., F-Hoffmann La-Roche, Illumina, Inc., and Thermo Fisher Scientific (Life Technologies Corporation).

Category:
  1. Introduction
  2. Executive Summary
    • Market Size Estimation (Revenue USD Million, 2014-2021)
    • Forecast Estimation (Revenue USD Million and CAGR%, 2017-2021)
  3. Research Methodology
  4. Market Landscape
    • Market Dynamics
      • Drivers
      • Barriers
      • Opportunities
    • Market Share Analysis
      • Companies
      • Products
    • Market Trends Analysis
      • Key success factors
      • Market Growth Rate
    • Market Attractiveness Analysis
    • Market Profitability Analysis
      • Buyer power
      • Supplier power
      • Barriers to entry
      • Threat of substitute products
      • Rivalry among firms in the industry
    • Distribution Channels
  5. Market Segmentation [refer Market Segments and Companies Tab]
    • Product Type (cells, media, serum, vaccine, protein, instrument, etc.)
    • Source Type
    • Reagents and Consumables Type
    • Diagnostic Test
    • Indication Type
    • Technology
    • Diagnostics, Therapeutic or Surgical Application
    • End User Groups
  6. Geography (Region, Country)
    • North America (U.S., Canada)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Rest of the World (Middle East & Africa)
  7. Company Profiles [refer Market Segments and Companies Tab]
    • Company Overview
    • Financial Snapshot (FY 2014-2016)
    • Product Portfolio
    • Business Strategies
    • Recent Developments
  8. Recommendations
  9. References

Transcriptomics Technologies Market

1. Technology
1.1. Gene Regulation
1.2. Microarrays
1.3. Next Generation Sequencing (NGS)
1.4. Polymerase Chain Reaction (PCR)

2. Application
2.1. Bioinformatics
2.2. Clinical Diagnostics
2.3. Comparative Transcriptomics
2.4. Drug Discovery and Research

3. Geography (Region, Country)
3.1. North America (U.S., Canada)
3.2. Latin America (Brazil, Mexico, Rest of LA)
3.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
3.4. Asia Pacific (Japan, China, India, Rest of APAC)
3.5. Rest of the World

4. Company Profiles
4.1. Affymetrix, Inc.
4.2. Agilent Technologies, Inc.
4.3. Bio-Rad Laboratories, Inc.
4.4. Danaher Corporation
4.5. F. Hoffmann-La Roche Ltd.
4.6. Illumina, Inc.
4.7. Life Technologies Corporation
4.8. LC Sciences, LLC
4.9. Qiagen N.V.
4.10. Sigma-Aldrich Corporation
4.11. Thermo Fisher Scientific, Inc.

Request market specific full ToC and sample pages for this report

Full Name*

Email*

Phone Number* [Please add country code]

Subject*

Message*

Translate »